Physician profile
Catherine Riley
NPI 1841493285
$9,604.02
in general payments reported to CMS, 2019-2025
54 companies · $2,189 in 2025
The $2,189 reported for 2025 was more than what 77% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,474 · 2020: $303 · 2021: $409 · 2022: $1,424 · 2023: $1,908 · 2024: $1,896 · 2025: $2,189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,544 · Consulting Fee: $350 · Education: $99.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,543.92 |
| Consulting Fee | $350.00 |
| Education | $99.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $968.40 | 2019-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Astrazeneca Pharmaceuticals LP | $918.45 | 2019-2025 | Fasenra, Tezspire, Airsupra |
| Janssen Pharmaceuticals, INC | $657.49 | 2021-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $536.94 | 2019-2025 | Ofev, Stiolto Respimat, Jascayd |
| Insmed, INC. | $523.91 | 2019-2024 | Arikayce |
| Harmony Biosciences LLC | $497.06 | 2020-2025 | Wakix |
| Mylan Specialty L.P. | $423.46 | 2019-2024 | Yupelri |
| Avadel Cns Pharmaceuticals, LLC | $359.84 | 2023-2025 | Lumryz |
| Regeneron Healthcare Solutions, INC. | $354.04 | 2020-2025 | Dupixent |
| Jazz Pharmaceuticals INC. | $336.90 | 2019-2025 | Xywav |
| Axsome Therapeutics, INC. | $301.53 | 2023-2025 | Sunosi |
| Abbvie INC. | $298.40 | 2022-2025 | Avycaz |
| Actelion Pharmaceuticals US, INC. | $252.06 | 2019-2025 | Opsumit, Uptravi |
| Genzyme Corporation | $248.64 | 2019-2025 | |
| Inspire Medical Systems, INC. | $231.09 | 2023-2025 | Inspire |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $211.56 | 2019-2023 | Xolair |
| United Therapeutics Corporation | $192.96 | 2019-2025 | Tyvaso, Tyvaso |
| Philips North America LLC | $186.32 | 2022-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Grifols USA, LLC | $174.80 | 2022-2025 | Prolastin-C Liquid |
| Amgen INC. | $169.88 | 2022-2025 | Tezspire |
| Pulmonx Corporation | $164.73 | 2024-2025 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Zephyr Endobronchial Valve |
| Viatris Specialty LLC | $130.81 | 2025 | Yupelri |
| Electromed, INC. | $111.27 | 2023-2025 | Smartvest |
| Abiomed | $101.69 | 2023 | Impella |
| Takeda Pharmaceuticals U.S.A., INC. | $101.07 | 2023-2025 | Aralast |
| Sanofi-Aventis U.S. LLC | $99.95 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $93.78 | 2022-2024 | Eliquis, Camzyos |
| Sunovion Pharmaceuticals INC. | $89.89 | 2019 | |
| Mallinckrodt Hospital Products INC. | $83.45 | 2020-2024 | Acthar |
| Mallinckrodt Enterprises LLC | $80.04 | 2019 | |
| Zoll Respicardia, INC. | $77.86 | 2024-2025 | Remede System |
| Pfizer INC. | $44.39 | 2022-2025 | |
| Paratek Pharmaceuticals, INC. | $40.15 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $39.78 | 2019 | |
| Ani Pharmaceuticals, INC. | $37.04 | 2023 | Purified Cortrophin Gel |
| Merck Sharp & Dohme LLC | $36.97 | 2019-2023 | Recarbrio, Zerbaxa |
| Tactile Systems Technology INC | $35.16 | 2024 | Entre Plus, Flexitouch Plus |
| Verona Pharma, INC. | $32.38 | 2025 | Ohtuvayre |
| Circassia INC. | $29.30 | 2019-2020 | |
| Portola Pharmaceuticals, LLC | $29.28 | 2020 | |
| Vifor Pharma, INC. | $29.08 | 2024 | Veltassa |
| Vapotherm INC | $29.00 | 2019 | |
| Biomerieux INC | $24.60 | 2023 | |
| Shionogi INC | $22.93 | 2025 | Fetroja |
| Optinose US, INC. | $22.72 | 2025 | |
| Idorsia Pharmaceuticals US INC | $22.30 | 2023 | Quviviq |
| Resmed Corp | $21.93 | 2023 | |
| Shire North American Group INC | $20.82 | 2019 | |
| Alexion Pharmaceuticals, INC. | $20.53 | 2023 | Ultomiris |
| Beigene USA, INC. | $19.97 | 2021 | |
| Baxter Healthcare | $18.65 | 2023 | Hillrom - Life 2000 Ventilation System |
| Ucb, INC. | $18.12 | 2021 | |
| Astellas Pharma US INC | $16.68 | 2024 | Cresemba |
| Nabriva Therapeutics, Plc | $13.97 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Riley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.